Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0331194B2 - - Google Patents
[go: Go Back, main page]

JPH0331194B2 - - Google Patents

Info

Publication number
JPH0331194B2
JPH0331194B2 JP11365683A JP11365683A JPH0331194B2 JP H0331194 B2 JPH0331194 B2 JP H0331194B2 JP 11365683 A JP11365683 A JP 11365683A JP 11365683 A JP11365683 A JP 11365683A JP H0331194 B2 JPH0331194 B2 JP H0331194B2
Authority
JP
Japan
Prior art keywords
substance
strain
culture
present
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11365683A
Other languages
Japanese (ja)
Other versions
JPS606197A (en
Inventor
Nozomi Ootake
Haruo Seto
Toshio Takatsu
Akira Shimazu
Tooru Sasaki
Takashi Shomura
Michiaki Iwata
Tetsuo Watanabe
Tatsuo Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP11365683A priority Critical patent/JPS606197A/en
Publication of JPS606197A publication Critical patent/JPS606197A/en
Publication of JPH0331194B2 publication Critical patent/JPH0331194B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規な14員環マクロライド抗生物質で
あるP−59B1物質とその製造法に関するもので
ある。 さらに詳しく述べると、本発明はミクロモノス
ポラ属に属するP−59B1物質生産菌を培地に培
養して得られた培養物から採取した新抗生物質P
−59B1物質とその製造法に関するものである。 本発明者等は、ミクロモノスポラ属に属するあ
る菌株の培養物中に、小麦黒銹病に対して防除活
性を示す物質が生産されていることを見出した。
その有効物質を培養物質から純粋に単離し、その
性状を調べた結果、既知の物質とは異なる新規な
構造を有する物質であることを確め、この有効物
質をP−59B1物質と命名して本発明を完成した。 本発明による新抗生物質P−59B1物質は、特
に小麦黒銹病菌の胞子の発芽管の伸張を阻止する
作用を有し小麦黒銹病に対しすぐれた防除効果を
有している。 本発明のP−59B1物質の理化学的性状は次の
通りである。 1 外 観:黄色油状の中性物質 2 分子式:C21H32O6(高分解能質量分析で実測
値380.2196、計算値380.2200) 3 紫外部吸収スペクトル:メタノール中で
215nm(ε6800),240nm(ε1400)に極大吸
収を示す。 4 紫外部吸収スペクトル:添付図面に示す。 5 薄層クロマトグラフイーのRf値:展開溶媒
ヘキサン−酢酸エチル(1:1)0.66 6 溶解性:低級アルコール、酢酸エチル、アセ
トン、クロロホルム、ベンゼンに可溶、水
に難溶である。 7 呈色反応: 硫酸反応、ヨウ素反応:陽性 ニンヒドリン反応、レミユー反応:陰性 8 安定性:酸性、アルカリ性で不安定である。 上記の物理化学的性質及び水素核磁気共鳴スペ
クトル、等よりP−59B1物質の化学構造は次の
通りと決定された。 本発明のP−59B1物質の抗菌活性を調べると、
小麦黒銹病菌夏胞子に対して1μg/mlの濃度で
発芽管の伸張を阻害し、4μg/mlの溶液を小麦
葉上に塗布することにより黒銹病の発症を防除し
た。 本発明はまた、ミクロモノスポラ属に属するP
−59B1物質生産菌を培養し、その培養物からP
−59B1物質を採取することを特徴とする新抗生
物質P−59B1物質の製造法を要旨とする。 本発明の方法に使用されるP−59B1物質生産
菌としては、その培養物中に採取するに充分な量
のP−59B1物質を生産する能力を有するもので
あれば、いかなるものであつてもよいが、この様
な菌株の一例としては、本発明者等により鹿児島
県牧園町の竹林で採取した土壌試料より新たに分
離された980−MC1(P−59)株がある。 980−MC1(P−59)株の菌学的性状は下記の
通りである。 本菌株の基生菌糸は放射状に分枝しながら長く
伸長し、通常は無隔壁または無分断である。胞子
は基生菌糸に直接または単軸分枝した短柄の先端
に単独に形成し、球形から倒洋ナシ形で、0.6〜
0.8×0.7〜1.1μm、表面はほゞ平滑でやゝ凹凸が
あり、成熟すると菌糸より容易に離脱して培地中
または培地表面に広がる。本菌株はコレミアまた
はそれに類似の菌糸束を空中に向けて形成するこ
とがあるが、真正の空中菌糸は観察されない。胞
子嚢、運動性胞子および菌核などは観察されな
い。 本菌株の培養性状は、後記の表1に示すよう
に、一般に、生育初期には黄橙色の集落を形成
し、2〜3日後から暗オリーブ灰色の胞子を着生
しはじめ、その着生量と成熟度によつて集落の色
が茶色から暗褐灰色または黒色に変化する。基生
菌糸の色と可溶性色素はPH指示性で、酸性で淡黄
色、塩基性で淡橙色から淡桃色を示す。 本菌株の生理、生化学的性状は表2に示す。本
菌は中温性で、メラノイド色素を生成せず、アミ
ラーゼとプロテアーゼの活性および硝酸塩の還元
能が陽性である。本菌のグルコシダーゼの活性は
α−ガラクトシダーゼとβ−キシロシダーゼが陽
性、α−マンノシダーゼが陰性である。炭素源の
利用能はα−メリビオース、ラフイノースが陽
性、L−ラムノース、マンニトールが陰性であ
る。本菌に含まれるジアミノピメリン酸
(A2pm)はメゾ型が主で、エル型が僅少である
が、3−ハイドロキシ型を含まない。 バージー氏細菌同定便覧の検索表により、上述
の性状を基準に検索すると、本菌株はミクロモノ
スポラ属(Micromonospora)に所属し、M.チ
ヤルシイ、M.ハロフイテイカ、M.ナラシノの三
種に近縁である。M.ハロフイテイカは胞子の大
きさが1.2μm以上である点と、A2pm(ジアミノピ
メリン酸)が3−ハイドロキシ型を含みエル型を
含まない点で、本菌株と種を異にする。M.ナラ
シノは硝酸塩環元能が陰性である点とβ−キシロ
シダーゼ活性が陰性である点で、本菌株と種を異
にする。M.チヤルシイはツアペツク氏寒天培地
上の生育が乏しい点とポテト切片上の生育が良好
である点で、本菌株と異なるが、種を異にするほ
どの差異ではないと判断される。よつて、本菌株
はM.チヤルシイに所属させ、ミクロモノスポ
ラ・チヤルシイ(Mioromonospora chalcea)、
980−MC1株と呼ぶことにする。 なお本菌株はミクロモノスポラ・チヤルシイ
(Micromonospora chalcea)980−MC1株とし
て工業技術院微生物工業技術研究所に昭和58年4
月21日以来寄託されており、受託番号は、
FERM P−7046である。
The present invention relates to substance P-59B1, a novel 14-membered ring macrolide antibiotic, and a method for producing the same. More specifically, the present invention relates to a new antibiotic P-59B1 substance-producing bacteria belonging to the genus Micromonospora, which is collected from a culture obtained by culturing the P-59B1 substance-producing bacteria in a medium.
-59B1 substance and its manufacturing method. The present inventors have discovered that a culture of a certain strain belonging to the genus Micromonospora produces a substance that exhibits a control activity against wheat rot.
As a result of pure isolation of the active substance from the cultured material and examination of its properties, it was confirmed that it was a substance with a new structure different from known substances, and this active substance was named P-59B1 substance. The invention has been completed. The new antibiotic substance P-59B1 according to the present invention has an excellent control effect on wheat rot, particularly by inhibiting the elongation of germ tubes of spores of the wheat rot fungus. The physical and chemical properties of the P-59B1 substance of the present invention are as follows. 1 Appearance: Yellow oily neutral substance 2 Molecular formula: C 21 H 32 O 6 (Actual value 380.2196 by high-resolution mass spectrometry, calculated value 380.2200) 3 Ultraviolet absorption spectrum: In methanol
It shows maximum absorption at 215nm (ε6800) and 240nm (ε1400). 4 Ultraviolet absorption spectrum: Shown in the attached drawing. 5 Rf value for thin layer chromatography: Developing solvent hexane-ethyl acetate (1:1) 0.66 6 Solubility: Soluble in lower alcohols, ethyl acetate, acetone, chloroform, and benzene, slightly soluble in water. 7 Color reaction: Sulfuric acid reaction, iodine reaction: Positive Ninhydrin reaction, Remieux reaction: Negative 8 Stability: Unstable under acidic and alkaline conditions. The chemical structure of the P-59B1 substance was determined to be as follows based on the above-mentioned physicochemical properties, hydrogen nuclear magnetic resonance spectrum, etc. When examining the antibacterial activity of the P-59B1 substance of the present invention,
The germ tube elongation of wheat rot fungus diaspores was inhibited at a concentration of 1 μg/ml, and a solution of 4 μg/ml was applied on wheat leaves to control the onset of black rust. The present invention also provides P. belonging to the genus Micromonospora.
−59B1 substance-producing bacteria are cultivated, and P from the culture is
The summary is a method for producing the new antibiotic P-59B1 substance, which is characterized by collecting the -59B1 substance. The P-59B1 substance-producing bacteria used in the method of the present invention may be any species as long as it has the ability to produce a sufficient amount of P-59B1 substance to be collected in its culture. An example of such a bacterial strain is strain 980-MC1 (P-59), which was newly isolated by the present inventors from a soil sample collected from a bamboo forest in Makisono Town, Kagoshima Prefecture. The mycological properties of the 980-MC1 (P-59) strain are as follows. The basal hyphae of this strain elongate while branching radially, and are usually septate-free or undivided. Spores are formed directly on basal hyphae or singly at the tips of short stalks with uniaxial branches, spherical to pear-shaped, 0.6 to
0.8 x 0.7 to 1.1 μm, the surface is almost smooth and slightly uneven, and when it matures, it easily separates from the hyphae and spreads in the medium or on the surface of the medium. This strain may form hyphal bundles of Coremia or similar hyphae to the air, but true aerial hyphae are not observed. Sporangia, motile spores, and sclerotia are not observed. As shown in Table 1 below, the culture characteristics of this strain generally form yellow-orange colonies at the early stage of growth, and after 2 to 3 days, dark olive-gray spores begin to settle, and the amount of colonization increases. The color of the colony changes from brown to dark brown-gray or black depending on the maturity level. The color and soluble pigment of the basal hyphae are pH-indicating, with pale yellow in acidic conditions and pale orange to pale pink in basic conditions. The physiological and biochemical properties of this strain are shown in Table 2. This bacterium is mesophilic, does not produce melanoid pigments, and has positive amylase and protease activities and nitrate reduction ability. Regarding the glucosidase activities of this bacterium, α-galactosidase and β-xylosidase are positive, and α-mannosidase is negative. The availability of carbon sources is positive for α-melibiose and raffinose, and negative for L-rhamnose and mannitol. Diaminopimelic acid (A 2 pm) contained in this bacterium is mainly of the meso type, with a small amount of the EL type, but does not contain the 3-hydroxy type. When searching for the above properties using the search table in Mr. Burgee's Bacteria Identification Handbook, we found that this strain belongs to the genus Micromonospora and is closely related to three species: M. charsii, M. halohuiteica, and M. narasino. be. M. halofiteica differs from this strain in that the size of its spores is 1.2 μm or more and that A 2 pm (diaminopimelic acid) contains the 3-hydroxy type and does not contain the L type. M. narasino differs from this strain in that it is negative for nitrate cyclogen ability and negative for β-xylosidase activity. Although M. charsii differs from this strain in that it grows poorly on Tuapetsk's agar medium and grows well on potato sections, it is judged that the differences are not enough to make it a different species. Therefore, this bacterial strain belongs to M. chalcii, Micromonospora chalcea,
Let's call it 980−MC1 strain. This strain was submitted to the Institute of Microbial Technology, Agency of Industrial Science and Technology as Micromonospora chalcea 980-MC1 strain in April 1982.
It has been deposited since April 21st, and the deposit number is:
It is FERM P-7046.

【表】【table】

【表】【table】

【表】 本菌株、すなわち980−MCI(P−59)株は他
の放線菌の場合にみられるようにその性状が変化
しやすく、たとえば紫外線、エツクス線、放射
線、薬品等を用いる人工的変異手段で変異しうる
ものであり、このような変異株であつてもP−
59B1物質の生産能を有するミクロモノスポラ属
の菌はすべて本発明の方法に使用することができ
る。 本発明の方法では、980−MC1(P−59)株を
通常、微生物が利用しうる栄養物を含有する培地
で培養する。たとえば、炭素源としてグルコー
ス、シユクロース、デキストリン、澱粉、水あ
め、糖みつ、植物油、動物油等を使用しうる。ま
た、窒素源として大豆粉、小麦胚芽、ペプトン、
肉エキス、酵母エキス、コーンステイ−プリカ
ー、硝酸ソーダ、硫酸アンモニウム等を使用しう
る。その他、必要に応じて炭酸カルシウム、塩化
カリウム、燐酸塩等の無機塩類を添加するほか、
菌の発育を助けP59B1物質の生産を促進するごと
き有機物および無機物を適当に添加することがで
きる。 培養法としては、一般の抗生物質生産の方法と
同じく好気的条件下での培養法であれば、いかな
る方法を適用してもよいが、深部培養が最も適し
ている。 培養に適した温度は20〜35℃であるが、多くの
場合26〜32℃の付近で培養を行なうのが好まし
い。P59B1物質の生産は振とう培養、タンク培養
共に2〜7日で蓄積が最高に達する。 本発明のP−59B1物質の検定に当つては、検
定菌として小麦黒銹病菌(パクシニア・グラミニ
ス)の寒天培地上での発芽管の伸張阻害を観察す
る方法が用いられる。すなわち、P−59B1物質
を含有する寒天培地上にパクシニア グラミニス
トリテイキ(Puccinia graminis f.sp.tritici)
レース21株の夏胞子をのせ、発芽管の伸張阻害の
程度を観察するものである。この方法によると、
P−59B1物質は1μg/mlの濃度においても、パ
クシニア・グラミニスの発芽管の伸張を阻害する
ことができる。 本発明によつて得られるP−51B1物質は中性
の脂溶性物質であり、前述の様な理化学性状を有
しているので、培養物からP−59B1物質の採取
にあたつては、その性状を利用して抽出、精製す
ることができる。すなわち、培養液中に蓄積され
たP−59B1物質は合成吸着剤であるダイヤイオ
ンHP−20等に吸着される。また水と混らない有
機溶剤、例えば酢酸エチルで抽出すればP−
59B1物質は有機溶剤層に抽出される。また培養
菌体中からはアセトン−水またはメタノール−水
で抽出される。 P−59B1物質をさらに精製するには、シリカ
ゲル・アルミナ等の吸着剤やセフアデツクスLH
−20(フアルマシア)などを用いるクロマトグラ
フイーやラジアルパツク8C18(ウオターズ社)等
を用いる高速液体クロマトクラフイーを行なうと
よい。 以上の様な方法により、あるいはこれらを適宜
組合わせることにより、高純度のP−59B1物質
が油状物質として得られる。 本発明は下記の実施例について具体的に説明す
るが、これに限定されるものではなく、ここに例
示しない多くの変形あるいは修飾手段を採用しう
ることはいうまでもないことである。 実施例 1 P59B1物質の製造 ミクロモノスポラ・チヤルシイ980MC1株(微
工研受託番号FERMP−7046)の胞子を、スター
チ1%、大豆粉3%(PH7)の液体培地1
(500ml三角フラスコ、10本使用)に接種し、28℃
で43時間振盪培養したものを種母とする。 デンプン25%、大豆粉1.5%、乾燥酵母0.2%、
炭酸カルシウム0.4%(PH7.4)の組成からなる液
体培地35に前記の種母を接種し、28℃で94時間
通気撹拌培養した(50ジヤーフアーメンター)。 ジヤーフアメンター2基分の培養物をシヤープ
レス遠心機により遠心分離を行なつた。得られた
上清50を合成吸着剤樹脂ダイヤイオンHP−20
(5)に吸着させ、50%メタノール水10で洗
浄後、10のメタノールにて溶出した。得られた
溶出液を2に減圧濃縮した後、酢酸エチル1
へ転溶した。酢酸エチル層を100mlの重曹水、100
mlの0.1規定塩酸で順次洗浄した後濃縮乾固した。
得られた粗抽出物をメタノールで充填したセフア
デツクスLH−20(直径3cm長さ50cm)の塔にの
せ、メタノールで展開するクロマトグラフイーを
行なつた。 溶出液を6gずつ分画し、パクシニア・グラミ
ニスに活性を持つフラクシヨンNo.25−29を集めて
減圧濃縮する。このことにより純度20〜30%の油
状物質を91mg得た。 この油状物質80mgについてラジアルパツク
8C18(ウオーターズ社)のカラムを用い70%メタ
ノール水を展開溶媒とする高速液体クロマトグラ
フイーを行なつた。 毎分2mlの速度で溶出すると、P59B1物質は注
入後12分を中心として溶出される。活性画分を濃
縮乾固し18mgの本発明のP59B1物質を得た。
[Table] This strain, 980-MCI (P-59) strain, is susceptible to changes in its properties, as seen in the case of other actinomycetes, such as artificial mutation using ultraviolet rays, X-rays, radiation, drugs, etc. It is possible to mutate by means, and even such a mutant strain has P-
All micromonospora bacteria capable of producing the 59B1 substance can be used in the method of the present invention. In the method of the invention, strain 980-MC1 (P-59) is typically cultured in a medium containing nutrients available to the microorganism. For example, glucose, sucrose, dextrin, starch, starch syrup, molasses, vegetable oil, animal oil, etc. can be used as the carbon source. In addition, soybean flour, wheat germ, peptone,
Meat extract, yeast extract, corn staple liquor, sodium nitrate, ammonium sulfate, etc. may be used. In addition to adding inorganic salts such as calcium carbonate, potassium chloride, and phosphates as necessary,
Organic and inorganic substances that aid the growth of bacteria and promote the production of P59B1 substances can be appropriately added. Any culture method may be used as long as it is carried out under aerobic conditions, as is the case with general antibiotic production methods, but deep culture is most suitable. The temperature suitable for culturing is 20-35°C, but in most cases it is preferable to culture around 26-32°C. Production of P59B1 substance reaches its maximum accumulation in 2 to 7 days for both shaking culture and tank culture. In assaying the P-59B1 substance of the present invention, a method is used in which inhibition of germ tube elongation is observed on an agar medium of wheat black rot fungus (Paccinia graminis) as a test bacterium. That is, Puccinia graminis f.sp. tritici was placed on an agar medium containing the P-59B1 substance.
The purpose is to place pedicel spores of Race 21 strain on the tube and observe the degree of inhibition of germ tube elongation. According to this method,
Even at a concentration of 1 μg/ml, the P-59B1 substance can inhibit the elongation of the germ tube of Paccinia graminis. The P-51B1 substance obtained by the present invention is a neutral fat-soluble substance and has the above-mentioned physical and chemical properties, so when collecting the P-59B1 substance from the culture, It can be extracted and purified using its properties. That is, the P-59B1 substance accumulated in the culture solution is adsorbed to a synthetic adsorbent such as Diaion HP-20. In addition, if extracted with an organic solvent that does not mix with water, such as ethyl acetate, P-
The 59B1 substance is extracted into the organic solvent layer. In addition, it can be extracted from the cultured bacterial cells with acetone-water or methanol-water. To further purify the P-59B1 substance, use adsorbents such as silica gel and alumina or Cephadex LH.
-20 (Pharmacia) or high performance liquid chromatography using Radial Pack 8C18 (Waters) or the like. By using the methods described above or by appropriately combining these methods, a highly purified P-59B1 substance can be obtained as an oily substance. Although the present invention will be specifically explained with reference to the following examples, it is not limited thereto, and it goes without saying that many variations and modification means not exemplified here can be adopted. Example 1 Production of P59B1 substance Spores of Micromonospora charsii strain 980MC1 (FEI accession number FERMP-7046) were placed in a liquid medium 1 containing 1% starch and 3% soybean flour (PH7).
(500ml Erlenmeyer flasks, 10 flasks used) at 28°C.
The seeds were cultured with shaking for 43 hours. 25% starch, 1.5% soybean flour, 0.2% dry yeast,
The seed mother was inoculated into liquid medium 35 having a composition of 0.4% calcium carbonate (PH 7.4), and cultured with aeration and stirring at 28° C. for 94 hours (50 jars). The cultures of two jar fermenters were centrifuged using a shear press centrifuge. The obtained supernatant 50% was mixed with synthetic adsorbent resin Diaion HP-20.
(5), washed with 10 portions of 50% methanol water, and eluted with 10 portions of methanol. The obtained eluate was concentrated under reduced pressure in 2 parts, and then 1 part in ethyl acetate was added.
It was transferred to Add 100ml of sodium bicarbonate solution to the ethyl acetate layer.
After sequentially washing with 0.1 mL of 0.1N hydrochloric acid, the mixture was concentrated to dryness.
The obtained crude extract was placed on a Sephadex LH-20 column (diameter: 3 cm, length: 50 cm) filled with methanol, and chromatography was carried out by developing with methanol. The eluate is fractionated into 6 g portions, fractions Nos. 25-29 having activity against Paccinia graminis are collected and concentrated under reduced pressure. This yielded 91 mg of an oil with a purity of 20-30%. Radial Pack for 80mg of this oily substance
High performance liquid chromatography was performed using an 8C18 (Waters) column and 70% methanol water as the developing solvent. When eluted at a rate of 2 ml per minute, the P59B1 substance is eluted around 12 minutes after injection. The active fraction was concentrated to dryness to obtain 18 mg of the P59B1 substance of the present invention.

【図面の簡単な説明】[Brief explanation of the drawing]

図面は本発明のP−59B1物質の赤外吸収スペ
クトル図(クロロホルム中)である。
The figure is an infrared absorption spectrum diagram (in chloroform) of the P-59B1 substance of the present invention.

Claims (1)

【特許請求の範囲】 1 下記の構造: を有する新規な14員環マクロライド抗生物質P−
59B1物質。 2 ミクロモノスポラ属に属するP−59B1物質
生産菌を培養し、その培養物からP−59B1物質
を採取することを特徴とする新抗生物質P−
59B1物質の製造法。
[Claims] 1. The following structure: A novel 14-membered ring macrolide antibiotic P-
59B1 substance. 2. A new antibiotic P- characterized by culturing P-59B1 substance-producing bacteria belonging to the genus Micromonospora and collecting the P-59B1 substance from the culture.
59B1 Manufacturing method of substance.
JP11365683A 1983-06-25 1983-06-25 Novel antibiotic substance p-59b1 and its preparation Granted JPS606197A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11365683A JPS606197A (en) 1983-06-25 1983-06-25 Novel antibiotic substance p-59b1 and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11365683A JPS606197A (en) 1983-06-25 1983-06-25 Novel antibiotic substance p-59b1 and its preparation

Publications (2)

Publication Number Publication Date
JPS606197A JPS606197A (en) 1985-01-12
JPH0331194B2 true JPH0331194B2 (en) 1991-05-02

Family

ID=14617802

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11365683A Granted JPS606197A (en) 1983-06-25 1983-06-25 Novel antibiotic substance p-59b1 and its preparation

Country Status (1)

Country Link
JP (1) JPS606197A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324300A (en) * 1997-04-14 1998-10-21 Merck & Co Inc Microbial Transformation Products With Antifungal Properties

Also Published As

Publication number Publication date
JPS606197A (en) 1985-01-12

Similar Documents

Publication Publication Date Title
Yuan et al. High production of pyoluteorin and 2, 4-diacetylphloroglucinol by Pseudomonas fluorescens S272 grown on ethanol as a sole carbon source
US5407826A (en) Isolated cultures of microorganisms of Clonostachys Cylindrospora, Gliocladium and Nectria Gliocladioides
KR0177839B1 (en) Novel thiomarinol derivatives and preparation method thereof
Venkata Dasu et al. Studies on production of griseofulvin
US3697650A (en) Antibiotic sl 3364
JPH0331194B2 (en)
CN110092758B (en) A novel alkaloid compound and verrucospora strain for preparing the compound by fermentation
JPH0331195B2 (en)
JP2710834B2 (en) FO-608A substance and method for producing the same
EP0413967B1 (en) Novel antibiotic
US4239690A (en) Antibiotics produced by Cytospora sp. W.F.P.L. 13A
CN115247131B (en) Trichoderma atroviride and metabolite and application thereof
CN114469908B (en) Preparation method and application of stemphol, an anti-Acinetobacter baumannii compound
JP3608210B2 (en) Novel compound MK7924 and process for producing the same
US4220718A (en) Antibiotics produced by Cytospora sp. W.F.P.L. 13A
JPH0374677B2 (en)
CN101812103B (en) 6-methy salicylic acid synthetase transformed by genetic engineering and combinatorial biosynthesis of spirocyclic acetoacetic acid lactone antiboitic
EP0260964A2 (en) New hapalindoles
JP4342048B2 (en) Antibiotics tuberacutomycin B, D and E and methods for their production
KR101088600B1 (en) Process for fermentation and purification for antibiotic compound from Nocardia sp. CS682
JPS6015318B2 (en) New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it
KR100383215B1 (en) A new fungal strain MT90049(KCTC 18043P), novel compound produced by this strain and their use
CN116445317A (en) New streptomyces albus strain for producing puromycin and application thereof
JPH05239023A (en) Physiologically active substance MBP039-06 and method for producing the same
JPH0680607A (en) Malbranicin